Bioprocessing

The global biopharmaceutical contract manufacturing market is anticipated to experience significant growth from 2024 to 2032. This market's expansion is driven by continuous technological innovations, increased research and development (R&D) investments, and strategic collaborations among

Biomanufacturing, the engineering of biological materials for products like pharmaceuticals, is poised for radical change. Historically reliant on specialized labor and manual processes, the sector is now at the cusp of a technological revolution powered by artificial intelligence (AI) and machine

The biopharmaceutical industry has long faced hurdles integrating advanced manufacturing technologies (AMTs) into commercial biomanufacturing. Despite the clear benefits of AMTs, including enhanced efficiency, scalability, and product quality, adoption rates remain sluggish. This article seeks to

The biopharmaceutical industry has been growing steadily, driven by the development of new modalities and biomanufacturing technologies. Traditional bioprocessing methods, while effective, are facing significant challenges as the complexity and diversity of biopharma pipelines increase. This has

In an exciting development, Scorpius Holdings has been selected as a member of the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV). This collaboration is expected to significantly enhance BARDA’s mission to accelerate the development of med

The ongoing evolution and novel advancements in filtration technology are essential for biologics manufacturing, as the complexity and size of therapeutic modalities increase. This evolution has introduced new challenges that require efficient and effective filtration systems to ensure the